Cleared Traditional

K203812 - Oxyfit Pulse Oximeter

K203812 is an FDA 510(k) clearance for Oxyfit Pulse Oximeter, manufactured by Shenzhen Viatom Technology Co., Ltd.. The device is a Class 2 Anesthesiology device with product code DQA cleared through the Traditional 510(k) pathway after a 680-day FDA review.

K203812 · Shenzhen Viatom Technology Co., Ltd. · Anesthesiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 2022
Decision
680d
Days
Class 2
Risk

K203812 is an FDA 510(k) clearance for the Oxyfit Pulse Oximeter. Classified as Oximeter (product code DQA), Class II - Special Controls.

Submitted by Shenzhen Viatom Technology Co., Ltd. (Shenzhen, CN). The FDA issued a Cleared decision on November 8, 2022 after a review of 680 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 870.2700 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Anesthesiology submissions.

View all Shenzhen Viatom Technology Co., Ltd. devices

FDA 510(k) Submission Details - K203812

510(k) Number K203812 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 28, 2020
Decision Date November 08, 2022
Days to Decision 680 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
540d slower than avg
Panel avg: 140d · This submission: 680d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DQA Device Classification - Class 2, Special Controls

Product Code DQA Oximeter
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2700
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Peers - DQA Oximeter

All 453
Devices cleared under the same product code (DQA) and FDA review panel - the closest regulatory comparables to K203812.
Oximeter (Model: JZK-301,JZK-303,JZK-305,JZK-307)
K213984 · Shenzhen Zhengkang Technology Co., Ltd. · Dec 2022
Empatica Health Monitoring Platform
K221282 · Empatica S.R.L. · Nov 2022
Polso Watch
K220351 · Chronisense Medical, Ltd. · Nov 2022
Pulse Oximeter (Model C101A2, C101B1, C101A3)
K221979 · Shenzhen Imdk Medical Technology Co., Ltd. · Oct 2022
YUWELL Finger Pulse Oximeter
K212385 · Jiangsu Yuyue Medical Equipment& Supply Co., Ltd. · Aug 2022
Masimo CARESCAPE SpO2 – Masimo with SpHb
K221953 · Masimo Corporation · Aug 2022